Short answer
Relay Therapeutics, Inc. (RLAY) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 financial results announced Feb 26, 2026: details in Exhibit 99.1 press release.
Relay Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 financial results announced Feb 26, 2026: details in Exhibit 99.1 press release
- Filing furnished, not filed: limits legal liability under Exchange Act Section 18, standard for earnings releases
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Relay Therapeutics, Inc. 8-K filings
Get the next RLAY 8-K as it lands
Follow RLAY for push alerts, or ask the research agent what this filing means.